Skip to main content
SpringerLink
Log in

Cost effectiveness may guide ACS treatment decisions

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. US dollars

Reference

  • Fanari Z, et al. Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review. American Journal of Cardiovascular Drugs : 12 Jun 2015. Available from: URL: http://doi.org/10.1007/s40256-015-0131-6

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost effectiveness may guide ACS treatment decisions. PharmacoEcon Outcomes News 731, 11 (2015). https://doi.org/10.1007/s40274-015-2240-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2240-5

Search

Navigation